comparemela.com

Latest Breaking News On - Meiragtx holdings - Page 4 : comparemela.com

Sam Altman rejoins OpenAI board

Sam Altman, CEO of OpenAI, has rejoined the company's Board of Directors, about five months since he was fired and subsequently rehired as the CEO. In addition to Altman, three new board members have joined OpenAI: Dr. Sue Desmond-Hellmann, Nicole Seligman, and Fidji Simo.

United-states
American
Bret-taylor
Sam-altman
Meta-facebook
Nicole-seligman
Melinda-gates-medical-research-institute
Intuitive-machines-inc
Council-of-advisors-on-science
Meiragtx-holdings
Counsel-at-sony-corporation
Sue-desmond-hellmann

MeiraGTx Holdings plc (NASDAQ:MGTX) Sees Significant Decline in Short Interest

MeiraGTx Holdings plc (NASDAQ:MGTX – Get Free Report) was the target of a large decrease in short interest during the month of January. As of January 31st, there was short interest totalling 1,410,000 shares, a decrease of 10.2% from the January 15th total of 1,570,000 shares. Based on an average daily volume of 258,300 shares, […]

Canada
Nasdaq
Meiragtx-holdings
Ensign-peak-advisors-inc
Royal-bank
Acadian-asset-management
Meiragtx-company-profile
Tower-research-capital
Get-free-report
Research-capital
Asset-management

MeiraGTx: Bota-Vec Program Advancing With Milestones Being Met (NASDAQ:MGTX)

MeiraGTx: Bota-Vec Program Advancing With Milestones Being Met (NASDAQ:MGTX)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Meiragtx-riboswitch
Meiragtx-holdings
Transcriptional-regulation-technology
Nasdaq
Johnson
American-academy-of-ophthalmology
X-linked-retinitis-pigmentosa
Transcription-regulation
Riboswitch-gene
X-linked-retinitis

MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals

MeiraGTx to receive $50 million milestone after initiation of the extension study for the Phase 3 LUMEOS clinical trial for botaretigene sparoparvovec for the treatment of X-linked retinitis.

London
City-of
United-kingdom
Jason-braco
Lifesci-communications
Janssen-pharmaceuticals-inc
Nasdaq
Johnson
Meiragtx-holdings
Janssen-pharmaceuticals
Alexandria-forbes
Quality-control

Reviewing MeiraGTx (NASDAQ:MGTX) & Alvotech (NYSE:ALVO)

MeiraGTx (NASDAQ:MGTX – Get Free Report) and Alvotech (NYSE:ALVO – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, earnings, risk, profitability and valuation. Institutional and Insider Ownership 64.8% of MeiraGTx shares are […]

Iceland
Reykjavik
C10
New-york
United-states
Meiragtx-holdings
Janssen-pharmaceuticals-inc
Get-free-report
Janssen-pharmaceuticals
Simponi-aria
Meiragtx

vimarsana © 2020. All Rights Reserved.